Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Federal Trade Commission
Moodys
Cipla
McKesson
Dow
Merck
Novartis
Citi
US Army
McKinsey

Generated: August 22, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 019678

« Back to Dashboard
NDA 019678 describes ENLON-PLUS, which is a drug marketed by Mylan Institutional and is included in two NDAs. It is available from one supplier. Additional details are available on the ENLON-PLUS profile page.

The generic ingredient in ENLON-PLUS is atropine sulfate; edrophonium chloride. There are twenty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the atropine sulfate; edrophonium chloride profile page.

Summary for NDA: 019678

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:0
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 019678

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ENLON-PLUS
atropine sulfate; edrophonium chloride
INJECTABLE;INJECTION 019678 NDA Mylan Institutional LLC 67457-192 67457-192-05 10 AMPULE in 1 CARTON (67457-192-05) > 5 mL in 1 AMPULE (67457-192-00)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:INJECTABLE;INJECTIONStrength0.14MG/ML;10MG/ML
Approval Date:Nov 6, 1991TE:RLD:Yes

Expired Orange Book Patents for NDA: 019678

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
ENLON-PLUS
atropine sulfate; edrophonium chloride
INJECTABLE;INJECTION019678-001Nov 6, 1991► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Boehringer Ingelheim
Cantor Fitzgerald
Novartis
QuintilesIMS
Accenture
Medtronic
US Army
UBS
US Department of Justice
Fish and Richardson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot